
|Articles|December 19, 2013
Generic version of Vfend now available
Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., has introduced voriconazole for oral suspension, an authorized generic version of Vfend.
Advertisement
Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., has introduced voriconazole for oral suspension, an authorized generic version of Vfend.
The antifungal agent will be offered in a dosage strength of 40 mg/mL. Voriconazole (Vfend, Pfizer) was approved for use in the treatment of invasive aspergillosis and the treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium spp in patients intolerant of, or refractory to, other therapy.
Full prescribing information is available
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
2
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
3
Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























